Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Diurnal variation of the human adipose transcriptome and the link to metabolic disease.
Loboda A, Kraft WK, Fine B, Joseph J, Nebozhyn M, Zhang C, He Y, Yang X, Wright C, Morris M, Chalikonda I, Ferguson M, Emilsson V, Leonardson A, Lamb J, Dai H, Schadt E, Greenberg HE, Lum PY. Loboda A, et al. Among authors: kraft wk. BMC Med Genomics. 2009 Feb 9;2:7. doi: 10.1186/1755-8794-2-7. BMC Med Genomics. 2009. PMID: 19203388 Free PMC article.
The effects of modifying in vivo cytochrome P450 3A (CYP3A) activity on etoricoxib pharmacokinetics and of etoricoxib administration on CYP3A activity.
Agrawal NG, Matthews CZ, Mazenko RS, Woolf EJ, Porras AG, Chen X, Miller JL, Michiels N, Wehling M, Schultz A, Gottlieb AB, Kraft WK, Greenberg HE, Waldman SA, Curtis SP, Gottesdiener KM. Agrawal NG, et al. Among authors: kraft wk. J Clin Pharmacol. 2004 Oct;44(10):1125-31. doi: 10.1177/0091270004268129. J Clin Pharmacol. 2004. PMID: 15342613 Clinical Trial.
Effect of aprepitant on the pharmacokinetics of intravenous midazolam.
Majumdar AK, Yan KX, Selverian DV, Barlas S, Constanzer M, Dru J, McCrea JB, Ahmed T, Frick GS, Kraft WK, Petty KJ, Greenberg HE. Majumdar AK, et al. Among authors: kraft wk. J Clin Pharmacol. 2007 Jun;47(6):744-50. doi: 10.1177/0091270007300807. Epub 2007 Apr 26. J Clin Pharmacol. 2007. PMID: 17463213 Clinical Trial.
Effects of ezetimibe on cyclosporine pharmacokinetics in healthy subjects.
Bergman AJ, Burke J, Larson P, Johnson-Levonas AO, Reyderman L, Statkevich P, Kosoglou T, Greenberg HE, Kraft WK, Frick G, Murphy G, Gottesdiener K, Paolini JF. Bergman AJ, et al. Among authors: kraft wk. J Clin Pharmacol. 2006 Mar;46(3):321-7. doi: 10.1177/0091270005284851. J Clin Pharmacol. 2006. PMID: 16490808 Clinical Trial.
The pharmacokinetics of taurolidine metabolites in healthy volunteers.
Gong L, Greenberg HE, Perhach JL, Waldman SA, Kraft WK. Gong L, et al. Among authors: kraft wk. J Clin Pharmacol. 2007 Jun;47(6):697-703. doi: 10.1177/0091270007299929. Epub 2007 Mar 29. J Clin Pharmacol. 2007. PMID: 17395893 Free article. Clinical Trial.
Double-blind crossover study to assess potential differences in cytochrome P450 3A4 activity in healthy subjects receiving ondansetron plus dexamethasone, with and without aprepitant.
Stoch SA, Gargano C, Valentine J, Braun MP, Murphy MG, Fedgchin M, Majumdar A, Pequignot E, Gottesdiener KM, Petty KJ, Panebianco D, Dean D, Kraft WK, Greenberg HE. Stoch SA, et al. Among authors: kraft wk. Cancer Chemother Pharmacol. 2011 Jun;67(6):1313-21. doi: 10.1007/s00280-010-1421-y. Epub 2010 Aug 24. Cancer Chemother Pharmacol. 2011. PMID: 20734049 Clinical Trial.
Potential for interactions between caspofungin and nelfinavir or rifampin.
Stone JA, Migoya EM, Hickey L, Winchell GA, Deutsch PJ, Ghosh K, Freeman A, Bi S, Desai R, Dilzer SC, Lasseter KC, Kraft WK, Greenberg H, Waldman SA. Stone JA, et al. Among authors: kraft wk. Antimicrob Agents Chemother. 2004 Nov;48(11):4306-14. doi: 10.1128/AAC.48.11.4306-4314.2004. Antimicrob Agents Chemother. 2004. PMID: 15504857 Free PMC article. Clinical Trial.
110 results